Estimation of Lifetime Risk of Cardiovascular Disease (IBERLIFERISK): A New Tool for Cardiovascular Disease Prevention in Primary Care.
Carlos Brotons, Irene Moral, Diana Fernández...
https://pubmed.ncbi.nlm.nih.gov/30097396Actively Recruiting
Age: 18Years +
FEMALE
Healthy Volunteers
ID07356817
Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications
Led by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Updated on 2026-01-21
1260
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
Sponsors
F
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead Sponsor
H
Hospital Sant Joan de Deu
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to understand how various factors influence the heart and blood vessel health of mothers 3 to 6 years after giving birth. It focuses on young women who had pregnancies with or without placental problems, such as preeclampsia or preterm delivery. The study explores how lifestyle choices, environmental exposures, and pregnancy complications affect cardiovascular risk, with the goal of developing better prediction and prevention strategies tailored for women. The study will assess about 1,800 women by examining heart function and blood vessel health through tests like blood pressure measurement, cardiac imaging, and biochemical markers. It will include detailed evaluations of pregnancy history, lifestyle habits, mental health, and environmental factors. Researchers will analyze data such as coronary artery scans, heart ultrasound, and blood tests to understand cardiovascular risks years after pregnancy. Participants will be involved in evaluations that include imaging tests like coronary computed tomography and magnetic resonance myocardial perfusion, blood sampling, heart ultrasound, and questionnaires about lifestyle and mental health. The study will measure outcomes such as hypertension, cardiac function, and major cardiovascular events occurring 3 to 6 years after pregnancy. This information will help create user-friendly tools, possibly mobile apps, to help women and doctors assess heart health risks. The study also emphasizes education, advocacy, and sharing findings with health professionals and the public.
CONDITIONS
Brief Title
Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications
Who Can Participate
Age: 18Years +
FEMALE
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Patients who participated in the BiSC, EuroPE, or AngioCor cohort studies
- Delivered a baby within the previous 3 to 6 years
- Willing to give written consent to participate in this study
You will not qualify if you...
- Unwillingness to participate in this study
- Probability of loss to follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Long-term Monitoring
Duration - 3 to 6 years after index pregnancy
Participants undergo cardiovascular risk assessment through biophysical, imaging, and biochemical evaluations 3 to 6 years after their index pregnancy. This includes assessments of heart function, blood pressure, coronary artery disease, and other cardiovascular markers, as well as lifestyle and environmental factors that may influence cardiovascular health.
1 to 2 visits depending on assessments
Trial Site Locations
Total: 1 location
1
Hospital de la Santa Creu i de Sant Pau
Barcelona, Spain, 08025
Actively Recruiting
Loading map...
Research Team
E
Elisa Llurba Olivé, PhD
P
Pablo García Manau, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Coronary Artery Calcium Distribution Is an Independent Predictor of Incident Major Coronary Heart Disease Events: Results From the Framingham Heart Study.
Maros Ferencik, Karol M Pencina, Ting Liu...
https://pubmed.ncbi.nlm.nih.gov/28956774Multicenter analytical evaluation of a high-sensitivity troponin T assay.
A K Saenger, R Beyrau, S Braun...
https://pubmed.ncbi.nlm.nih.gov/21219893NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
James L Januzzi, Roland van Kimmenade, John Lainchbury...
https://pubmed.ncbi.nlm.nih.gov/162936382017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Paul K Whelton, Robert M Carey, Wilbert S Aronow...
https://pubmed.ncbi.nlm.nih.gov/29146535